The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 7, Pages 1931
Publisher
MDPI AG
Online
2018-07-02
DOI
10.3390/ijms19071931
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma
- (2018) M. -L. Nairismägi et al. LEUKEMIA
- Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma
- (2018) Haijun Wen et al. NATURE MEDICINE
- Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes
- (2017) Siok-Bian Ng et al. HAEMATOLOGICA
- The diagnosis and management of NK/T-cell lymphomas
- (2017) Eric Tse et al. Journal of Hematology & Oncology
- Checkpoint inhibitors in hematological malignancies
- (2017) Chi Young Ok et al. Journal of Hematology & Oncology
- RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC
- (2017) V Selvarajan et al. LEUKEMIA
- CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
- (2017) Marian L. Burr et al. NATURE
- AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination
- (2017) Michael C. Haffner et al. Nature Communications
- Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling
- (2017) Ming Wang et al. Oncotarget
- Comparison of Different Antibody Clones for Immunohistochemistry Detection of Programmed Cell Death Ligand 1 (PD-L1) on Non–Small Cell Lung Carcinoma
- (2017) Edwin R. Parra et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes
- (2017) Siok-Bian Ng et al. HAEMATOLOGICA
- Association between extranodal natural killer/T-cell lymphoma and hepatitis B viral infection: a case-control study
- (2017) Kefeng Wang et al. Journal of Cancer
- EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma
- (2016) Junli Yan et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
- (2016) Javeed Iqbal et al. BLOOD REVIEWS
- FrequentBCORaberrations in extranodal NK/T-Cell lymphoma, nasal type
- (2016) Akito Dobashi et al. GENES CHROMOSOMES & CANCER
- Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation
- (2016) Zhang Zhang et al. HEMATOLOGICAL ONCOLOGY
- Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States
- (2016) Scott V. Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic options in peripheral T cell lymphoma
- (2016) Yaping Zhang et al. Journal of Hematology & Oncology
- PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma
- (2016) Xi-wen Bi et al. Journal of Hematology & Oncology
- Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study
- (2016) Zheng Li et al. LANCET ONCOLOGY
- Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation
- (2016) Martina Minnich et al. NATURE IMMUNOLOGY
- Targeting CD38 in Refractory Extranodal Natural Killer Cell–T-Cell Lymphoma
- (2016) Parameswaran Hari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors
- (2016) L A Jung et al. ONCOGENE
- Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells
- (2016) Maryam Abbaspour Babaei et al. Drug Design Development and Therapy
- Authors' Reply
- (2015) Christian Schmitt et al. AMERICAN JOURNAL OF PATHOLOGY
- CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type
- (2015) Liang Wang et al. ANNALS OF HEMATOLOGY
- Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) F. d'Amore et al. ANNALS OF ONCOLOGY
- Receptor-type tyrosine-protein phosphatase directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma
- (2015) Y.-W. Chen et al. BLOOD
- Global Promoter Methylation Analysis Reveals Novel Candidate Tumor Suppressor Genes in Natural Killer Cell Lymphoma
- (2015) C. Kucuk et al. CLINICAL CANCER RESEARCH
- Epstein–Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotype
- (2015) Siok-Bian Ng et al. LEUKEMIA & LYMPHOMA
- Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
- (2015) Lu Jiang et al. NATURE GENETICS
- Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
- (2015) Henk M. Lokhorst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of microRNA-10a, microRNA-342-3p and their predicted target gene TIAM1 in extranodal NK/T-cell lymphoma, nasal type
- (2015) HAOBO HUANG et al. Oncology Letters
- Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
- (2015) Can Küçük et al. Nature Communications
- Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type
- (2015) Seungbok Lee et al. Oncotarget
- Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis
- (2015) Seok Jin Kim et al. Lancet Haematology
- HACE1, a Potential Tumor Suppressor Gene on 6q21, Is Not Involved in Extranodal Natural Killer/T-Cell Lymphoma Pathophysiology
- (2014) Nouhoum Sako et al. AMERICAN JOURNAL OF PATHOLOGY
- Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
- (2014) J. Iqbal et al. BLOOD
- Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
- (2014) Jason R. Westin Clinical Lymphoma Myeloma & Leukemia
- Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion
- (2014) P. Strati et al. HAEMATOLOGICA
- TAK1-ECSIT-TRAF6 Complex Plays a Key Role in the TLR4 Signal to Activate NF-κB
- (2014) Sae Mi Wi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type
- (2014) Li Liang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- High-resolution genome-wide analysis identified recurrent genetic alterations in NK/T-cell lymphoma, nasal type, which are associated with disease progression
- (2014) Lin Sun et al. MEDICAL ONCOLOGY
- Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hosts
- (2014) Siok-Bian Ng et al. Orphanet Journal of Rare Diseases
- Activated Janus Kinase 3 expression not by activating mutations identified in Natural Killer/T-cell lymphoma
- (2014) Ying Guo et al. PATHOLOGY INTERNATIONAL
- Molecular underpinning of extranodal NK/T-cell lymphoma
- (2013) Yenlin Huang et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity
- (2013) J. Yan et al. BLOOD
- PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
- (2013) B. J. Chen et al. CLINICAL CANCER RESEARCH
- Diagnostic and Prognostic Value of Circulating miR-221 for Extranodal Natural Killer/T-Cell Lymphoma
- (2013) Hong-Qiang Guo et al. DISEASE MARKERS
- Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology
- (2013) Ayoma D Attygalle et al. HISTOPATHOLOGY
- MicroRNA function in NK-cell biology
- (2013) Aimee M. Beaulieu et al. IMMUNOLOGICAL REVIEWS
- Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
- (2013) Catherine M. Bollard et al. JOURNAL OF CLINICAL ONCOLOGY
- JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma
- (2013) A Bouchekioua et al. LEUKEMIA
- Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404)
- (2013) Kristen Ganjoo et al. LEUKEMIA & LYMPHOMA
- Rare occurrence ofJAK3mutations in natural killer cell neoplasms in Japan
- (2013) Hiroshi Kimura et al. LEUKEMIA & LYMPHOMA
- MicroRNA regulation of natural killer cells
- (2013) Ryan P. Sullivan et al. Frontiers in Immunology
- HACE1 Is a Tumor Suppressor Gene Candidate in Natural Killer Cell Neoplasms
- (2012) Can Küçük et al. AMERICAN JOURNAL OF PATHOLOGY
- Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters
- (2012) F. Lemonnier et al. BLOOD
- Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring
- (2012) Anthony E Rizzardi et al. Diagnostic Pathology
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- TET2andDNMT3AMutations in Human T-Cell Lymphoma
- (2012) Lucile Couronné et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA Profiling of Epstein-Barr Virus-Associated NK/T-Cell Lymphomas by Deep Sequencing
- (2012) Natalie Motsch et al. PLoS One
- Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma
- (2012) Ghee Chong Koo et al. Cancer Discovery
- Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma
- (2011) S.-B. Ng et al. BLOOD
- Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses
- (2011) K. Karube et al. BLOOD
- Epstein-Barr virus-mediated dysregulation of human microRNA expression
- (2011) Sirie Godshalk et al. CELL CYCLE
- MicroRNA-146a Downregulates NF B Activity via Targeting TRAF6 and Functions as a Tumor Suppressor Having Strong Prognostic Implications in NK/T Cell Lymphoma
- (2011) J. H. Paik et al. CLINICAL CANCER RESEARCH
- Extranodal NK/T-Cell Lymphoma: Toward the Identification of Clinical Molecular Targets
- (2011) Christian Schmitt et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
- (2011) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of microRNA-150 as a tumor suppressor in malignant lymphoma
- (2011) A Watanabe et al. LEUKEMIA
- Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies
- (2011) Kwan Yeung Wong et al. PLoS One
- Epstein-Barr Virus BART9 miRNA Modulates LMP1 Levels and Affects Growth Rate of Nasal NK T Cell Lymphomas
- (2011) Rajesh Ramakrishnan et al. PLoS One
- Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling
- (2010) Siok-Bian Ng et al. JOURNAL OF PATHOLOGY
- Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro
- (2010) J Iqbal et al. LEUKEMIA
- Aurora kinase A is a target of Wnt/ -catenin involved in multiple myeloma disease progression
- (2009) J. Dutta-Simmons et al. BLOOD
- Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type
- (2009) Y. Huang et al. BLOOD
- Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia
- (2009) Y. Yamanaka et al. BLOOD
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs
- (2009) Fernando Cruz-Guilloty et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies
- (2009) J Iqbal et al. LEUKEMIA
- STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma
- (2009) P Coppo et al. LEUKEMIA
- A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians
- (2009) Yoichiro Kamatani et al. NATURE GENETICS
- Epstein-Barr Virus in Lymphoproliferative Processes
- (2008) Siok-Bian Ng et al. ADVANCES IN ANATOMIC PATHOLOGY
- Role of platelet-derived growth factors in physiology and medicine
- (2008) J. Andrae et al. GENES & DEVELOPMENT
- Epstein–Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-κB pathway
- (2008) Graziana Gatto et al. NUCLEIC ACIDS RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started